We take our inspiration, and our name, from the principle of exaptation – the concept that a trait which evolved for one purpose can be harnessed to serve an entirely different function.
Using the power of genome editing and synthetic biology, we’ve converted nature’s ultimate first-responder cell into a modular chassis, ready to be programmed to treat disease. We’re arming our delivery platform to carry a broad spectrum of therapeutic payloads – cytokines, antibodies, nucleic acids and more. We’ve designed these delivery vehicles to activate only on recognition of their chosen targets, unleashing their powerful cargo with exquisite precision.
We’re developing our multi-modal therapies to treat the most complex of diseases including cancer and autoimmunity.
Using the power of genome editing and synthetic biology, we’ve converted nature’s ultimate first-responder cell into a modular chassis, ready to be programmed to treat disease. We’re arming our delivery platform to carry a broad spectrum of therapeutic payloads – cytokines, antibodies, nucleic acids and more. We’ve designed these delivery vehicles to activate only on recognition of their chosen targets, unleashing their powerful cargo with exquisite precision.
We’re developing our multi-modal therapies to treat the most complex of diseases including cancer and autoimmunity.